European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week
MT newswire2026/10/09 15:1411:14 AM EDT, 10/09/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Friday morning, rising 0.42% to 1,881.24 on the S&P Europe Select ADR Index, which is little changed for the week so far. From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and telecommunications company Nokia (NOK), which rose 2.6 % and 2.3% respectively. They were followed by medical device maker EDAP TMS (FOCL), which was up 2.3%, and internet browser company Opera (OPRA), 1.7% higher. The decliners from continental Europe were led by 3D printer company Materialise (MTLS) and brewing company Anheuser-Busch InBev (BUD), which fell 3% and 0.5% respectively. They were followed by biopharmaceutical company argenx (ARGX) and lender ING (ING), which were down 0.3% and 0.2% respectively. The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and pharmaceutical company Silence Therapeutics (SLN), which climbed 11% and 6% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which increased 2.1% and 2% respectively. The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and telecommunications operator Vodafone (VOD), which dropped 6.2% and 4.8% respectively. They were followed by utilities company National Grid (NGG) and alcoholic beverage company Diageo (DEO), which lost 1.2% and 0.4% respectively.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Bonds Could Become the Hedge Against AI Selloff as Correlation Turns Negative
JPMorgan lowered Boeing's target price to $240.
"For the first time in history" Annual Guidance Released in Advance! JPMorgan Maintains 'Overweight' Rating for ASM International (ASMIY.US), Earnings Outlook May Continue to Improve
JPMorgan maintains an Overweight rating on ASMI with a target price of 1,174 euros, stating that this is the first time the company has provided guidance for 2027. The outlook is highly visible, and profit expectations may be revised up by a low double-digit percentage.